TransMedics Group, Inc.

Ownership Transactions Reported by 18 Insiders

Symbol
TMDX on Nasdaq
Industry
Electromedical & Electrotherapeutic Apparatus
Location
200 Minuteman Road, Andover, MA

Insiders trading volume in the past year

TransMedics Group, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Waleed H. Hassanein President & CEO, Director $71.6M +$837K +1.18% Aug 6, 2025
Edwin M. Kania Jr Director $28.4M May 22, 2025
James R. Tobin Director $16.4M May 22, 2025
Stephen Gordon Chief Financial Officer $2.9M Jun 3, 2024
Tamer I. Khayal Chief Commercial Officer $2.75M -$585K -17.5% Mar 3, 2025
Nicholas Corcoran SVP of Supply Chain and Operations, Exhibit List: Exhibit 24 - Power of Attorney $2.7M Feb 24, 2025
Miriam Provost VP, Global Regulatory Affairs $2.1M Dec 13, 2023
Anil P. Ranganath Senior Vice President, General Counsel and Secretary $1.95M -$95.9K -4.69% Jun 9, 2025
David Weill Director $1.5M -$90.7K -5.69% May 22, 2025
John F. Sullivan VP of Quality & Engineering $1.29M Aug 30, 2021
Gerardo Hernandez Chief Financial Officer $1.28M Feb 24, 2025
John F. Carey VP of Operations $1.27M Feb 1, 2023
Laura Damme VP, Clinical Affairs $512K Feb 20, 2023
Raines Merilee Director $375K May 22, 2025
Thomas James Gunderson Director $375K May 22, 2025
Stephanie Lovell Director $375K May 22, 2025
Edward M. Basile Director $360K -$2.41M -87% Aug 4, 2025
Rakesh P. Godhani Chief Digital Officer Aug 4, 2021

Recent Insider Transactions by Companies or Individuals for TransMedics Group, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.